Nobivac NXT HCPCh

Authorised

This medicine is authorised for use in the European Union

feline calicivirosis, feline rhinotracheitis, feline panleucopenia and feline chlamydiosis (live) vaccine

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Product details

• Name of medicine:
  Nobivac NXT HCPCh
• Active substance:
  • chlamydia felis, strain Baker, live
  • felid herpesvirus 1, strain G2620A, Live
  • feline calicivirus (FCV), strain F9, live
  • feline panleucopenia virus (FPL), strain MW-1, live
• International non-proprietary name (INN) or common name:
  feline calicivirosis, feline rhinotracheitis, feline panleucopenia and feline chlamydiosis (live) vaccine

Pharmacotherapeutic group

• Immunologicals for felidae
• Live bacterial and viral vaccines
• feline panleucopenia virus / parvovirus + feline rhinotracheitis virus + feline calicivirus + chlamydia

Authorisation details

• EMA product number:
  EMEA/V/C/006703

Assessment history

Initial marketing authorisation documents

CVMP summary of positive opinion for Nobivac NXT HCPCh

Adopted Reference Number: EMA/CVMP/106114/2026